Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 15, 2004 02:14 ET | Source: Crucell N.V.

Crucell Signs PER.C6(TM) License Agreement with Biogen Idec

LEIDEN, The Netherlands, Jan. 15, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a non-exclusive PER.C6(TM) technology...
January 13, 2004 02:15 ET | Source: Crucell N.V.

Crucell Grants Pfizer an Exclusive License on West Nile Virus Vaccine for Horses

LEIDEN, The Netherlands, Jan. 13, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL), (Nasdaq:CRXL) announced today that it has granted U.S.-based Pfizer Inc. (NYSE:PFE) an...
January 12, 2004 10:37 ET | Source: Crucell N.V.

Invitation Conference Call Full Year Results 2003

LEIDEN, The Netherlands, Jan. 12, 2004 (PRIMEZONE) -- Monday, January 26, 2004 at 15.00 Central European Time 14.00 London Time 9.00 New York Time Please call: +31 20 531 5871 15 minutes...
January 07, 2004 09:52 ET | Source: Crucell N.V.

Aventis and Crucell Announce Strategic Agreement to Develop and Commercialize Novel Influenza Vaccines

LYON, France and LEIDEN, The Netherlands, Jan. 7, 2004 (PRIMEZONE) -- Aventis (NYSE:AVE) and Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that they have entered into a strategic...
December 08, 2003 02:18 ET | Source: Crucell N.V.

Crucell Signs PER.C6(tm) Cell Line Development Service Agreement

LEIDEN, Netherlands, Dec. 08, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a service agreement with U.S.-based...
November 21, 2003 07:20 ET | Source: Crucell N.V.

Crucell Presents Update on In-house Product Development Programs at Analyst Meeting

LEIDEN, The Netherlands, Nov. 21, 2003 (PRIMEZONE) -- Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) presents a comprehensive update on the company's in-house product development programs today during...
November 19, 2003 02:08 ET | Source: Crucell N.V.

Crucell Appoints Jean-Yves Guichoux, Executive Vice President, Development

LEIDEN, The Netherlands, Nov. 19, 2003 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today the appointment of Jean-Yves Guichoux, M.D., to Executive Vice President, Development....
November 17, 2003 02:13 ET | Source: Crucell N.V.

Crucell to Webcast Analyst Day on November 21st, 2003

LEIDEN, The Netherlands, Nov. 17, 2003 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL), invites investors, the media and the general public to view a live video webcast of its Analyst Day...
November 14, 2003 02:18 ET | Source: Crucell N.V.

Crucell Presents Encouraging Results of its Malaria Vaccine Program

LEIDEN, The Netherlands and LAS VEGAS, Nov. 14, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Nasdaq:CRXL) (Euronext:CRXL) presented encouraging study results on the efficacy of an...
October 27, 2003 02:19 ET | Source: Crucell N.V.

Crucell Announces Resignation of M.A. de Haan

LEIDEN, The Netherlands, Oct. 27, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today the resignation of Supervisory Board Vice Chairman, Mr....